© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 20, 2018
The FDA approved fostamatinib disodium hexahydrate (Tavalisse) tablets for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia. RDR discusses with Dr James Bussel.
Research Suggests Pediatric Psoriasis Linked to Anxiety, Depression
Esketamine Infusion May Prevent Post-Surgery Sleep Disturbances
Study Suggests PCSK9 Inhibitors May Reduce Psoriasis Risk